ORLANDO, Fla. – In an effort to help with production, drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine, a Biden administration official confirmed Tuesday.
Officials have said J&J faced unexpected production issues with its vaccine. The company produced only 3.9 million doses ahead of receiving emergency use authorization from the FDA on Saturday.
The company says it is on pace to deliver 100 million doses by the end of June. The assistance from Merck was expected to help J&J meet its production commitments and expand supply even further, but the administration did not immediately provide specifics.